Preoperative Pan-Immune-Inflammation Value for the Differential Diagnosis and Prognostic Assessment of Ovarian Tumors: A Retrospective Cohort Study
Diagnostics · 16.06.2026 · 16 (12) · 1873
DOI: 10.3390/diagnostics16121873 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diagnostics, online erschienen am 16.06.2026. Verfasst von Süleyman Özen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, İzmir City Hospital, İzmir 35540, Turkey. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Preoperative differentiation of benign, borderline, and malignant ovarian tumors remains challenging. The pan-immune-inflammation value (PIV), a composite inflammation-based biomarker derived from routine blood counts, may contribute to ovarian tumor characterization. This study aimed to evaluate the diagnostic and prognostic significance of PIV in ovarian tumors.
Methods
This retrospective single-center cohort study included 316 patients with histopathologically confirmed ovarian tumors classified as benign (n = 139), borderline (n = 61), or malignant (n = 116). Preoperative inflammatory indices were calculated from peripheral blood samples obtained within 24 h before surgery. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis and multivariable logistic regression. Progression-free survival (PFS) and overall survival (OS) were evaluated in malignant cases with available follow-up.
Results
Inflammatory indices increased significantly from benign to borderline and malignant tumors (p < 0.001 for all). Among inflammatory markers, PIV demonstrated the highest diagnostic performance, with an area under the curve (AUC) of 0.852 (95% CI 0.808–0.893), sensitivity of 75.0%, and specificity of 80.5%. CA-125 demonstrated the highest overall diagnostic accuracy (AUC 0.978, 95% CI 0.961–0.991). Pairwise ROC analyses showed consistent discriminatory performance of PIV across ovarian tumor comparisons. In multivariable analysis, age, tumor size, ln(CA-125), and ln(PIV) were independently associated with malignancy (all p < 0.05). The combined CA-125 + PIV model demonstrated a statistically significant but modest improvement in diagnostic performance compared with CA-125 alone. During a median follow-up of 26.9 months (IQR 22.2–32.5), PIV was not significantly associated with PFS or OS.
Conclusions
PIV demonstrated the highest diagnostic performance among evaluated inflammatory indices and may provide complementary information for preoperative epithelial ovarian tumor assessment. However, CA-125 remained the most accurate standalone biomarker, and the prognostic value of PIV appeared limited.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, İzmir City Hospital, İzmir 35540, Turkey.
ORCID-Profile: Süleyman Özen
Zitieren
APA
Özen, S., & Sancı, M. (2026). Preoperative Pan-Immune-Inflammation Value for the Differential Diagnosis and Prognostic Assessment of Ovarian Tumors: A Retrospective Cohort Study. Diagnostics, 16(12), 1873. https://doi.org/10.3390/diagnostics16121873
Vancouver
Özen S, Sancı M. Preoperative Pan-Immune-Inflammation Value for the Differential Diagnosis and Prognostic Assessment of Ovarian Tumors: A Retrospective Cohort Study. Diagnostics. 2026;16(12):1873. doi:10.3390/diagnostics16121873
BibTeX
@article{zen2026,
author = {Özen, Süleyman and Sancı, Muzaffer},
title = {Preoperative Pan-Immune-Inflammation Value for the Differential Diagnosis and Prognostic Assessment of Ovarian Tumors: A Retrospective Cohort Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {12},
pages = {1873},
doi = {10.3390/diagnostics16121873}
}
EUVIMED